Biotech | November 18, 2022
Strand Life Sciences launches ‘Strand Genomic Wellness’
Strand’s new offering will help people better understand and manage diseases through genomic sequencing
Strand’s new offering will help people better understand and manage diseases through genomic sequencing
The company has reported total income of Rs. 4.59 crores during the period ended September 30, 2022
The Group will continue to make proactive investments of its management resources in the life science business
The company has reported total income of Rs. 519.31 crores during the period ended September 30, 2022.
In Q2 FY23, the overall performance of the company continued to be strong despite the ongoing geo-political challenges impacting supply chain and costs
The move will add new global talent to Cytel’s Strategic Consulting group
Dr. Mahdavi will lead Ginkgo's commercial efforts in the growing areas of bio-reagents, cell and gene therapies and new biopharmaceutical modalities.
The acquisition reaffirms Infosys’ commitment to help global life sciences companies
Suven Life Sciences has reported total income of Rs. 3.97 crores during the period ended June 30, 2022
Strand Life Sciences has sequenced a total of 12800 samples from July, 2021 to June, 2022, and identified more than a 100 lineages circulating in Bengaluru
Subscribe To Our Newsletter & Stay Updated
